The Transgenic and Chimeric Mouse Facility has been continuously funded by the NCI CCSG since 1989. Drs. Stephen Liebhaber and Nancy Cooke, Professors of Genetics and Medicine, have provided leadership as Co- Directors to this Shared Resource since 1993. Both individuals are experienced investigators with considerable expertise in transgenic and chimeric mouse generation and analysis, and mammalian gene targeting. An experienced technical team led by Dr. Jean Richa provides expertise in a range of transgenic technologies, enabling the facility to regularly introduce new and improved services. Among the services provided by the Transgenic and Chimeric Mouse Facility are: generation of transgenic mice via microinjections of DNA into fertilized oocyte; generation of chimeric mice via injection of embryonic stem cells into blastocysts; direct genome editing (Zn finger, TALEN, and CRISPR/Cas9) by microinjection of RNA and DNA into fertilized embryos; embryo re-derivation; embryo and sperm cryopreservation; in vitro fertilization; centralized and monitored cryopreservation storage; and maintenance of generally useful mouse lines including those for recombination-activation gene expression. The facility uses state-of-the-art laser conditioning of the zona to facilitate IVF and has intracytoplasmic sperm injection capability on-line to complement the in vitro fertilization service. Newly developed services during the current funding period include the major expansion of cryopreservation services with corresponding expansion of the centralized and dedicated cryopreservation facility, integration of mouse ES microinjection service with a centralized gene knock-out core facility, and direct genome editing by Zn-finger, TALEN and CRISPR-Cas9 technologies. In the reporting period (10/01/13- 09/30/14), Cancer Center members accounted for 46% of total Facility users and those with peer-reviewed funding accounted for 42%. This compares favorably with our request for 21% of the total budget from the CCSG. Additional Institutional support is provided in the form of funding for equipment maintenance and facility infrastructure upgrades and maintenance.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016520-42
Application #
9535701
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Marino, Michael A
Project Start
Project End
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
42
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Fraietta, Joseph A; Lacey, Simon F; Orlando, Elena J et al. (2018) Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat Med 24:563-571
Shroff, Rachna T; Hendifar, Andrew; McWilliams, Robert R et al. (2018) Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation. JCO Precis Oncol 2018:
Williams, Austin D; Reyes, Sylvia A; Arlow, Renee L et al. (2018) Is Age Trumping Genetic Profiling in Clinical Practice? Relationship of Chemotherapy Recommendation and Oncotype DX Recurrence Score in Patients Aged Ann Surg Oncol 25:2875-2883
Anton, Lauren; Sierra, Luz-Jeannette; DeVine, Ann et al. (2018) Common Cervicovaginal Microbial Supernatants Alter Cervical Epithelial Function: Mechanisms by Which Lactobacillus crispatus Contributes to Cervical Health. Front Microbiol 9:2181
Krump, Nathan A; Liu, Wei; You, Jianxin (2018) Mechanisms of persistence by small DNA tumor viruses. Curr Opin Virol 32:71-79
Bengsch, Bertram; Ohtani, Takuya; Khan, Omar et al. (2018) Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells. Immunity 48:1029-1045.e5
Nair, Praful R; Alvey, Cory; Jin, Xiaoling et al. (2018) Filomicelles Deliver a Chemo-Differentiation Combination of Paclitaxel and Retinoic Acid That Durably Represses Carcinomas in Liver to Prolong Survival. Bioconjug Chem 29:914-927
Bhagwat, Neha; Dulmage, Keely; Pletcher Jr, Charles H et al. (2018) An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clusters. Sci Rep 8:5035
Raposo-Ferreira, Talita M M; Brisson, Becky K; Durham, Amy C et al. (2018) Characteristics of the Epithelial-Mesenchymal Transition in Primary and Paired Metastatic Canine Mammary Carcinomas. Vet Pathol 55:622-633
Kasner, Margaret T; Mick, Rosemarie; Jeschke, Grace R et al. (2018) Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition. Invest New Drugs 36:657-666

Showing the most recent 10 out of 1047 publications